XML 82 R57.htm IDEA: XBRL DOCUMENT v3.25.0.1
REVENUES - ACCOUNTS RECEIVABLES, UNBILLED SERVICES, AND UNEARNED REVENUE (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Gross unbilled services $ 160.5 $ 192.9  
Less reserve for unbilled services (7.6) (7.5)  
Contract with Customer, Asset, after Allowance for Credit Loss, Current 152.9 185.4  
Unearned revenue 392.2 421.7  
Deferred Revenue, Revenue Recognized 113.0 78.9 $ 99.7
Accounts Receivable, Allowance for Credit Loss (44.7) (32.7) (30.8)
Allowance for Credit Loss (52.3) (40.2) (41.3)
Accounts Receivable, Credit Loss Expense (Reversal) 14.6 6.3  
Accounts Receivable, Allowance for Credit Loss, Writeoff (2.2) (4.4)  
Unbilled Services, Allowance for Credit Loss (7.6) (7.5) $ (10.5)
Unbilled Services, Credit Loss Expense (Reversal) 0.1 0.0  
Unbilled Services, Allowance for Credit Loss, Write Off 0.0 3.0  
Unbilled Services, Allowance for Credit Loss, Write Off 0.0 (3.0)  
Credit Loss Expense (Reversal) 14.7 6.3  
Accounts Receivable, Allowance for Credit Loss, Writeoff (2.2) (7.4)  
Financing Receivable, Allowance for Credit Loss, Foreign Currency Translation 0.4    
Accounts receivable, net 1,944.1 1,913.3  
LabCorp Diagnostics [Member]      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Accounts Receivable, before Allowance for Credit Loss 1,259.3 1,135.2  
Biopharma Laboratory Services      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Accounts Receivable, before Allowance for Credit Loss 729.5 810.8  
Accounts Receivable, Allowance for Credit Loss $ (44.7) $ (32.7)